CA Stock MarketDetailed Quotes
MDP Medexus Pharmaceuticals Inc
- 3.300
- +0.050+1.54%
15min DelayMarket Closed Dec 27 16:00 ET
81.35MMarket Cap27.05P/E (TTM)
3.410High3.230Low20.08KVolume3.410Open3.250Pre Close66.73KTurnover3.41052wk High0.09%Turnover Ratio24.65MShares1.47052wk Low0.122EPS TTM73.51MFloat Cap11.250Historical HighLossP/E (Static)22.27MShs Float0.880Historical Low-0.014EPS LYR5.54%Amplitude--Dividend TTM1.73P/B1Lot Size--Div YieldTTM
About Medexus Pharmaceuticals Inc Company
Medexus Pharmaceuticals Inc is a specialty pharmaceutical company with a powerful North American commercial platform and a growing portfolio of inventive and rare disease treatment solutions. The company's focus is on the therapeutic areas of oncology, hematology, rheumatology, auto-immune diseases, allergy, and dermatology.
Company Profile
SymbolMDP
Company NameMedexus Pharmaceuticals Inc
Founded2013
MarketTSE
Employees82
Fiscal Year Ends03-31
Address10 King Street East Suite 600
CityToronto
CountryCAN
Zip CodeM5C 1C3
Phone+1 514 762-2626
Websitehttps://www.medexus.com
Company Executives
- Name
- Position
- Salary
- Kenneth d’Entremont
- Chief Executive Officer and Director
- --
- Brendon Buschman
- Chief Financial Officer
- --
- Richard Labelle
- Chief Operating Officer
- --
- Michael Mueller
- Chairman of the Board
- --
- Menassie Taddese, M.B.A.
- Independent Director
- --
- Dr. Harmony P. Garges, M.D.
- Independent Director
- --
- Nancy Phelan
- Independent Director
- --
- Stephen Nelson
- Independent Director
- --
- Benoit Gravel
- Independent Director
- --
- Ian C Wildgoose Brown
- General Counsel and Corporate Secretary
- --
Heat List
CA
Overall
Symbol
Price
% Chg
No Data